Mimedx (MDXG) Change in Taxes (2016 - 2022)
Mimedx's (MDXG) quarterly Change in Taxes came in at -$52000.0 in Q4 2022, down 144.07% year-on-year from $118000.0 in Q4 2021, and up 1.89% quarter-over-quarter from -$53000.0 in Q3 2022.
Mimedx (MDXG) Change in Taxes (2016 - 2022) Analysis & Trends
Mimedx has disclosed Change in Taxes across 7 years of filings, most recently posting -$52000.0 for Q4 2022.
- Change in Taxes for Q4 2022 came in at -$52000.0, down 144.07% year-over-year; the trailing twelve-month figure through Dec 2022 was -$39000.0 (up 99.58% YoY), and the FY2022 annual result was -$39000.0, up 99.58% from the prior year.
- Change in Taxes came in at -$52000.0 for Q4 2022 at Mimedx, up from -$53000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $10.7 million in Q1 2020 to a low of -$9.5 million in Q3 2021.
- The 5-year median for Change in Taxes is $11000.0 (2018), against an average of $2400.0.
- Across the five-year window, Change in Taxes plunged 8350.0% in 2019 and surged 89158.33% in 2020, its largest moves.
- Mimedx's Change in Taxes stood at $10000.0 in 2018, then slumped by 8350.0% to -$825000.0 in 2019, then increased by 2.06% to -$808000.0 in 2020, then jumped by 114.6% to $118000.0 in 2021, then plunged by 144.07% to -$52000.0 in 2022.
- The last three Change in Taxes figures came in at -$52000.0 (Q4 2022), -$53000.0 (Q3 2022), and $129000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Mimedx | 534.41 Mn | 374.63 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -52,000.00 |
| Dec 31, 2022 | -52,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | -63,000.00 |
| Mar 31, 2022 | -63,000.00 |
| Dec 31, 2021 | 118,000.00 |
| Dec 31, 2021 | 118,000.00 |
| Sep 30, 2021 | -9.51 Mn |
| Sep 30, 2021 | -9.51 Mn |
| Jun 30, 2021 | 147,000.00 |
| Jun 30, 2021 | 147,000.00 |
| Mar 31, 2021 | -54,000.00 |
| Mar 31, 2021 | -54,000.00 |
| Dec 31, 2020 | -808,000.00 |
| Dec 31, 2020 | -808,000.00 |
| Sep 30, 2020 | 153,000.00 |
| Sep 30, 2020 | 153,000.00 |